Disruptive Tech Research
  • About
  • Media
  • Research
  • Subscribe
  • Log in
Select Page
RESN: Time To Lock In Our 5G Gains

RESN: Time To Lock In Our 5G Gains

by Lou Basenese | Feb 15, 2022 | RESN

Resonant Inc. (RESN) announced it’s being acquired for $4.50 per share by long-term strategic partner, Murata

RESN: Signed, Sealed, Delivered

RESN: Signed, Sealed, Delivered

by Lou Basenese | Oct 2, 2019 | RESN

Resonant Inc. (RESN) announced the closing of a $19 million strategic deal with Murata, the world’s largest RF module manufacturer

RESN: Major Revaluation Imminent As $16 Million Murata Deal Marches Toward Completion

RESN: Major Revaluation Imminent As $16 Million Murata Deal Marches Toward Completion

by Lou Basenese | Aug 23, 2019 | RESN

Shares of Resonant Inc. (RESN) are perking up, rallying 20%+ in the last two weeks. Here’s what’s behind the move and why shares could rally another 150% or more

Resonant Inc. (RESN): Whoomp! There “It” Is?

Resonant Inc. (RESN): Whoomp! There “It” Is?

by Lou Basenese | Jul 9, 2019 | RESN

This morning, Resonant Inc. (RESN) announced three new license agreements with an existing customer. Here are three reasons shares are rallying on the news…

Resonant Inc. (RESN): Lies, Damn Lies and Wall Street

Resonant Inc. (RESN): Lies, Damn Lies and Wall Street

by Lou Basenese | Jun 20, 2019 | RESN

Shares of Resonant Inc. (RESN) plunged yesterday on unfounded financing rumors. Here’s why we’re maintaining our bullishness and looking to buy more

RESN Reminder: We’re Waiting For Go, Not Godot

RESN Reminder: We’re Waiting For Go, Not Godot

by Lou Basenese | Apr 15, 2019 | RESN

Here are five reasons why RF filter pure-play, Resonant Inc. (RESN) is poised for a revenue and share price ramp to $6.50 (or higher)

« Older Entries

Your account

Sign in

Research Links

  • Real-Time Blog
  • Active Recs
  • Archive

Recent Posts

  • Q2 2022 Portfolio Review & Outlook
  • ATOM: Lands Another “Major” Foundry Customer, Plus 10 Takeaways From Q1 Report
  • [IMNM] Biotech Absurdity
  • [Video] Cue Biopharma Q&A Session With Dr. D.J. Verret
  • [Video] ATOM: 5 Key Takeaways From The Q4 2021 Report
  • RESN: Time To Lock In Our 5G Gains
  • [CUE] “That Data Is Amazing!” So Why Is The Stock Down?